» Articles » PMID: 37458982

African ZIKV Lineage Fails to Sustain Infectivity in an in Vitro Mimetic Urban Cycle

Overview
Specialty Microbiology
Date 2023 Jul 17
PMID 37458982
Authors
Affiliations
Soon will be listed here.
Abstract

Zika virus (ZIKV) is an arbovirus maintained in nature in two distinct cycles of transmission: urban and sylvatic. Each cycle includes specific vertebrate and invertebrate hosts, and through alternate infections, a conserved consensus sequence is maintained that might vary depending on the cycle. The current study aimed to investigate the ability of ZIKV and ZIKV to maintain an infectious cycle by alternating passages in cells mimicking the urban (UC) and semi-sylvatic (SC) cycles. The complete genome of the original inoculum and the last passages for each cycle were sequenced by Sanger. Ten passages were performed, as planned, for ZIKV UC, ZIKV SC, and ZIKV SC. ZIKV SC showed significant variation in viral titers along the passages, suggesting that the virus is not well adapted to the non-human primate host. ZIKV passage in UC was abrogated in the third passage, showing the inability of the African lineage to sustain cycles in human cells, suggesting a low capacity to establish an urban cycle. Several mutations were found in both strains along the passages, but not occurring at equivalent positions. Further studies are needed to elucidate whether any of these specific mutations affect viral fitness. ZIKV strains behave differently in artificial transmission cycles in vitro: Brazilian ZIKV was able to establish urban and semi-sylvatic cycles in vitro. African ZIKV proved unable to cycle among human and mosquito cells and is compatible only with the semi-sylvatic cycle. The main mutations arose in the NS2A region after artificial transmission cycles for both ZIKV strains but not at equivalent positions.

References
1.
Dick G . Epidemiological notes on some viruses isolated in Uganda; Yellow fever, Rift Valley fever, Bwamba fever, West Nile, Mengo, Semliki forest, Bunyamwera, Ntaya, Uganda S and Zika viruses. Trans R Soc Trop Med Hyg. 1953; 47(1):13-48. DOI: 10.1016/0035-9203(53)90021-2. View

2.
Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D . Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet. 2016; 387(10033):2125-2132. PMC: 4909533. DOI: 10.1016/S0140-6736(16)00651-6. View

3.
de Magalhaes-Barbosa M, Prata-Barbosa A, Robaina J, Raymundo C, Lima-Setta F, da Cunha A . Trends of the microcephaly and Zika virus outbreak in Brazil, January-July 2016. Travel Med Infect Dis. 2016; 14(5):458-463. DOI: 10.1016/j.tmaid.2016.09.006. View

4.
Oliveira W, Araujo de Franca G, Carmo E, Duncan B, de Souza Kuchenbecker R, Schmidt M . Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis. Lancet. 2017; 390(10097):861-870. DOI: 10.1016/S0140-6736(17)31368-5. View

5.
Calvet G, Aguiar R, Melo A, Sampaio S, de Filippis I, Fabri A . Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis. 2016; 16(6):653-660. DOI: 10.1016/S1473-3099(16)00095-5. View